Cargando…
The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome
BACKGROUND: Acute coronary syndrome is the major cause of death in developed countries. Despite its high prevalence, there is still a strong need for new biomarkers which permit faster and more accurate diagnostics and new therapeutic drugs. The basis for this challenge lay in improving our understa...
Autores principales: | Laborde, Carlos M, Alonso-Orgaz, Sergio, Mourino-Alvarez, Laura, Moreu, José, Vivanco, Fernando, Padial, Luis R, Barderas, María G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451929/ https://www.ncbi.nlm.nih.gov/pubmed/26038678 http://dx.doi.org/10.1186/1477-5956-12-43 |
Ejemplares similares
-
Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome
por: Laborde, Carlos M., et al.
Publicado: (2013) -
iTRAQ proteomic analysis of extracellular matrix remodeling in aortic valve disease
por: Martin-Rojas, Tatiana, et al.
Publicado: (2015) -
Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals
por: Baldan-Martin, Montserrat, et al.
Publicado: (2018) -
Proteomic Biomarkers of Atherosclerosis
por: Vivanco, F., et al.
Publicado: (2008) -
An Optimal Protocol to Analyze the Rat Spinal Cord Proteome
por: Gil-Dones, F., et al.
Publicado: (2009)